Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients With Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e31821529c3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pazopanib Maintenance After First-Line Etoposide and Platinum Chemotherapy in Patients With Extensive Disease Small-Cell Lung Cancer: A Multicentre, Randomised, Placebo-Controlled Phase II Study (KCSG-LU12-07)

British Journal of Cancer
Cancer ResearchOncology
2018English

Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients With Extensive-Stage Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2009English

A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Cancer Management and Research
Oncology
2019English

A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2011English

JCSE01.10 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase II Clinical Trial of the Epothilone B Analog, Ixabepilone, in Patients With Non–Small-Cell Lung Cancer Whose Tumors Have Failed First-Line Platinum-Based Chemotherapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

P1.12-04 a Ph3 Study of Niraparib as Maintenance Therapy in 1L Platinum Responsive Extensive Disease Small Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Phase II Study of Consolidation Amrubicin After Concurrent Chemoradiotherapy in Patients With Limited-Stage Small-Cell Lung Cancer

In Vivo
BiochemistryMedicineGeneticsPharmacologyMolecular Biology
2020English

P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy